TABLE 1.
Characteristics of VRE-positive patients included in the study to compare the effects of a 5-week course of oral administration of Lactobacillus rhamnosus Lcr35 with those of a placebo on VRE intestinal carriage clearance
| Patient no. | Arm | Age (yr) | Other VRE-positive colonization site | Previous antibiotic therapy | Antibiotic therapy during treatment (no. of days) |
|---|---|---|---|---|---|
| 1 | Placebo | 82 | None | Amoxicillin-clavulanic acid | None |
| 2 | Placebo | 84 | Urine | Ofloxacin | Ofloxacin (9) |
| 3 | Lcr35 | 75 | Urine | Ciprofloxacin | None |
| Vancomycin | |||||
| Metronidazole | |||||
| 4 | Lcr35 | 52 | Urine | Cefotaxime | Norfloxacin (77) |
| Norfloxacin | |||||
| 5 | Lcr35 | 75 | None | Imipenem | None |
| Ceftriaxone | |||||
| 6 | Lcr35 | 92 | Urine | Vancomycin | None |
| Ceftriaxone | |||||
| Amoxicillin | |||||
| Metronidazole | |||||
| 7 | Lcr35 | 66 | Urine | Linezolid | None |
| Teicoplanin | |||||
| Ofloxacin | |||||
| Ticarcillin | |||||
| 8 | Lcr35 | 89 | None | Amoxicillin-clavulanic acid | None |
| Ofloxacin | |||||
| Amoxicillin |